UBS’s VIROPHARMA INC VPHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-13,600
Closed -$678K 11415
2013
Q4
$678K Buy
13,600
+12,300
+946% +$550K ﹤0.01% 3985
2013
Q3
$51K Buy
1,300
+1,100
+550% +$36K ﹤0.01% 6854
2013
Q2
$6K Buy
+200
New +$5.28K ﹤0.01% 9196

UBS's VPHM Position: Q1 2014 in Review

UBS sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 20,136 shares — an estimated $1M sold.

UBS first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $1M in Q4 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

  • UBS reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
  • UBS sold 20,136 VIROPHARMA INC shares in Q1 2014, an estimated $1M.
  • UBS first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
  • UBS's VIROPHARMA INC position peaked at $1M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.